Related Experiment Video
Updated: Jan 14, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Branch retinal vein occlusion as a manifestation of systemic vasculopathy in CADASIL: a multimodal imaging case
Figen Bezci Aygun1, Ceren Özkorkmaz1, Sibel Kadayıfcılar1
1Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey.
Insights
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) can affect retinal veins, as shown in a case of branch retinal vein occlusion (BRVO). This highlights the importance of regular eye exams for early detection of systemic vascular disease in CADASIL patients.
Area of Science:
- Ophthalmology
- Neurology
- Genetics
Background:
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary small vessel disease linked to NOTCH3 gene mutations.
- While primarily affecting cerebral arterioles, CADASIL shows increasing evidence of systemic vascular involvement.
- Ocular manifestations, specifically retinal venous abnormalities like branch retinal vein occlusion (BRVO), are rare and poorly understood in CADASIL.
Purpose of the Study:
- To report a rare case of branch retinal vein occlusion (BRVO) in a patient with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL).
- To emphasize the potential for CADASIL-related vasculopathy to affect the retinal venous system.
- To highlight the significance of ocular imaging in recognizing systemic microvascular disease.
Main Methods:
- Case report of a 63-year-old male with decreased vision and floaters.
- Multimodal ocular imaging to assess retinal abnormalities.
- Genetic testing to confirm NOTCH3 gene variants.
Main Results:
- The patient presented with macular edema, intraretinal hemorrhages, and superior temporal BRVO.
- Genetic analysis confirmed a pathogenic NOTCH3 variant (c.317G>A; p.Cys106Tyr).
- The patient received intravitreal bevacizumab and dexamethasone implants for management.
Conclusions:
- CADASIL can manifest with retinal venous system involvement, such as BRVO.
- Ocular examination and imaging are crucial for identifying systemic microvascular disease in CADASIL.
- BRVO may be an underrecognized sign of CADASIL, necessitating regular ophthalmic screening and collaborative care.
Background:
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary small vessel disease caused by mutations in the NOTCH3 gene. While it predominantly affects cerebral arterioles, emerging evidence indicates systemic vascular involvement. Ocular manifestations, particularly venous abnormalities such as branch retinal vein occlusion (BRVO), are exceedingly rare and not well characterized in CADASIL.
Case Presentation:
We report a case of a 63-year-old male presenting with decreased vision and floaters in the left eye. Multimodal imaging revealed macular edema, intraretinal hemorrhages, and superior temporal BRVO. Systemic risk factors were excluded. Genetic testing confirmed heterozygous pathogenic NOTCH3 variant c.317G>A (p.Cys106Tyr) and a variant of uncertain significance c.1774C>A (p.Arg592Ser). Based on this diagnosis, family members were referred for genetic counseling. The patient received intravitreal bevacizumab followed by dexamethasone implants due to recurrent cerebrovascular events and concerns regarding anti-VEGF systemic safety.
Conclusion:
This case underscores that CADASIL-related vasculopathy may extend to the retinal venous system. Detailed ocular imaging can support early recognition of systemic microvascular disease. BRVO in CADASIL patients may represent an underrecognized manifestation, supporting the need for regular ophthalmic evaluation and interdisciplinary management.
More Related Videos
07:23Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
Published on: March 26, 2020
10:24Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
Published on: February 19, 2014